2016
DOI: 10.1038/nrd.2016.75
|View full text |Cite
|
Sign up to set email alerts
|

Targeting adipose tissue in the treatment of obesity-associated diabetes

Abstract: Adipose tissue regulates numerous physiological processes, and its dysfunction in obese humans is associated with disrupted metabolic homeostasis, insulin resistance and type 2 diabetes mellitus (T2DM). Although several US-approved treatments for obesity and T2DM exist, these are limited by adverse effects and a lack of effective long-term glucose control. In this Review, we provide an overview of the role of adipose tissue in metabolic homeostasis and assess emerging novel therapeutic strategies targeting adi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
440
0
9

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 544 publications
(457 citation statements)
references
References 303 publications
8
440
0
9
Order By: Relevance
“…It was estimated that about 300,000 people die each year from obesity and related causes, which puts this disorder as the second leading cause of death. In fact, being both overweight and obese increases the risk of several diseases and health conditions such as high triglycerides, cholesterol, diabetes, heart disease, high blood pressure, tumors (breast, colon, and endometrial), sleep disorders, and respiratory problems [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…It was estimated that about 300,000 people die each year from obesity and related causes, which puts this disorder as the second leading cause of death. In fact, being both overweight and obese increases the risk of several diseases and health conditions such as high triglycerides, cholesterol, diabetes, heart disease, high blood pressure, tumors (breast, colon, and endometrial), sleep disorders, and respiratory problems [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Adiponectin is an adipocyte-derived hormone that displays a range of beneficial cardiometabolic properties including anti-inflammatory and insulin sensitizing effects [283,295]. Paradoxically, circulating adiponectin levels are reduced in obesity and this 'hypoadiponectinemia' contributes to the aetiology of obesity-associated diseases [283,295]. Consistent with this, humans with genetic polymorphisms that reduce adiponectin production and mice lacking adiponectin typically develop cardiovascular dysfunction and or type 2 diabetes [252,283].…”
Section: Introductionmentioning
confidence: 66%
“…The increase in prevalence and severity of obesity related cardiometabolic diseases continues to drive efforts to identify novel and efficacious therapeutic approaches [295]. One such strategy is to identify pharmacological approaches to increase adiponectin production [283].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations